Overcoming obstacles to repurposing for neurodegenerative disease

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer’s Drug Discovery Foundation (ADDF) and the Micha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shineman, Diana W, Alam, John, Anderson, Margaret, Black, Sandra E, Carman, Aaron J, Cummings, Jeffrey L, Dacks, Penny A, Dudley, Joel T, Frail, Donald E, Green, Allan, Lane, Rachel F, Lappin, Debra, Simuni, Tanya, Stefanacci, Richard G, Sherer, Todd, Fillit, Howard M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184781/
https://www.ncbi.nlm.nih.gov/pubmed/25356422
http://dx.doi.org/10.1002/acn3.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184781/
https://www.ncbi.nlm.nih.gov/pubmed/25356422
http://dx.doi.org/10.1002/acn3.76

Ejemplares similares